Advertisement

Archiv für die gesamte Virusforschung

, Volume 43, Issue 4, pp 315–319 | Cite as

Laboratory infection with Zika virus after vaccination against yellow fever

  • A. R. Filipe
  • C. M. V. Martins
  • Helena Rocha
Article

Summary

One of the authors contracted a Zika virus infection during laboratory work. Subsequent studies revealed an immunological response of the anamnestic type due to preceding yellow fever vaccinations which rendered difficult etiological diagnosis had it not been possible to isolate the virus from the serum sample collected during the acute phase of the disease.

The authors comment on the possible importance of similar cases encountered in tropical countries when dignosis is based merely on the serological conversion from the acute phase to the convalescent phase of the disease.

Keywords

Infectious Disease Virus Infection Serum Sample Acute Phase Similar Case 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Brès, P.: Données récentes apportées par les enquêtes sérologiques sur la prévalence des arbovirus en Afrique, avec référence spéciale à la fièvre jaune. Bull. Wld Hlth Org.43, 223–267 (1970).Google Scholar
  2. 2.
    Casals, J.: Antigenic classification of arthropod-borne viruses. Proc. 6th Int. Congr. trop. Med. Malar.5, 34–47 (1959).Google Scholar
  3. 3.
    Casals, J.: Procedures for identification of arthropod-borne viruses. Bull. Wld Hlth Org.24, 723–734 (1961).Google Scholar
  4. 4.
    Clarke, D. H., andJ. Casals: Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Amer. J. trop. Med. Hyg.7, 561–573 (1958).Google Scholar
  5. 5.
    Comité d'experts de la fièvre jaune. Org. mond. Santé. Sér. Rapp. techn.479, Genève, 1971.Google Scholar
  6. 6.
    Filipe, A. R., R. G.Carvalho, A.Relvas, and V. M.Casaca: to be published.Google Scholar
  7. 7.
    Hammon, W. McD., andT. H. Work: Arbovirus infection in man. In: Diagnostic Procedures for Viral and Rickettsial Diseases, 3rd Ed. pp. 268–311. New York: Amer. Publ. Hlth Ass., 1964.Google Scholar
  8. 8.
    Kärber, G.: Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn-Schmiedberg's Arch. exp. Path. Pharmak.162, 480–483 (1931).Google Scholar
  9. 9.
    Schlesinger, R. W., L. Gordon, J. W. Frankel, J. W. Winter, P. R. Patterson, andW. R. Dorrance: Clinical and serological response of man to immunization with attenuated Dengue and yellow fever viruses. J. Immunol.77, 352–364 (1956).PubMedGoogle Scholar
  10. 10.
    Sérié, C., J. Casals, R. Panthier, P. Brès etM. C. Williams: Études sur la fièvre jaune en Ethiopie. 2. Enquête sérologique sur la population humaine. Bull. Wld Hlth Org.38, 843–854 (1968).Google Scholar
  11. 11.
    Simpson, D. I. H.: Zika virus infection in man. Trans. Roy. Soc. trop. Med. Hyg.58, 335–338 (1964).PubMedGoogle Scholar
  12. 12.
    Simpson, D. I. H.: Arbovirus diseases. Brit. med. Bull.28, 10–15 (1972).PubMedGoogle Scholar
  13. 13.
    Wisseman, C. L., Jr., andB. H. Sweet: Immunological studies with group B arthropod-borne virus. I — Broadened neutralizing antibody spectrum induced by by strain 17 D yellow fever in human subjects previously infected with Japanese encephalitis virus. Amer. J. trop. Med. Hyg.11, 550–561 (1962).Google Scholar

Copyright information

© Springer-Verlag 1973

Authors and Affiliations

  • A. R. Filipe
    • 1
    • 2
  • C. M. V. Martins
    • 1
    • 2
  • Helena Rocha
    • 1
    • 2
  1. 1.Instituto de Higiene e Medicina TropicalLisboaPortugal
  2. 2.Faculdade de VeterináriaLourenço MarquesMoçambique

Personalised recommendations